Introduction
Acinetobacter baumannii has emerged as leading opportunistic pathogens and nosocomial pathogen worldwide. [1] This isolates is among the most common isolates from intensive care units (ICUs) in most hospitals in Iran. Infection with A. baumannii is becoming a serious problem, particularly in Iran. [2] [3] [4] [5] A . baumannii has emerged as a common worldwide problem as a nosocomial pathogen in patients and high infection-associated morbidity and Indian Journal of Medical Microbiology vol. 33, No. 1 clones in west of Iran and to determine the distribution of pulsotypes. Also our isolates for the presence of genes bla OXA-23-like , bla OXA-24-like , bla OXA-51-like and bla OXA-58-like by PCR is determined.
Statistical analysis
The results were analyzed by Chi-square test using SSPS 16 software. Continuous variables were compared with one-way analysis of variance. Variables were analyzed by Chi-square test. A P < 0.05 was considered to indicate signifi cance.
Materials and Methods

Microbial collection
Isolates of Acinetobacter obtained from blood, urine and sputum were collected from two hospitals in Kermanshah between March 2010 and December 2011. The isolates were identifi ed by conventional biochemical methods and confi rmed by API 20NE kit (version 6.0, bio-Mérieux, Marcy L'Etoile, France). [18] We did the Kirby-Bauer method of disk diffusion for all isolates with CLSI guidelines [19] for: amikacin (AN: 30 μg), ceftriaxone (CRO: 30 μg), ciprofl oxacin (CIP: 5 μg), trimethoprim/sulfamethoxazole (TS: 30 μg), gatifl oxacin (GAT: 5 μg), colistin (CL: 10 μg), gentamicin (GM: 10 μg), imipenem (IMP: 10 μg), meropenem (MEM: 10 μg), piperacillin (PRL: 100 μg), polymyxin B (PB: 300 unit), levofl oxacin (LVF: 5 μg), minocyclin (MIN: 30 μg), mezlocillin (MEZ: 75 μg), tetracycline (TET: 30 μg), tobramycin (TOBI: 10 μg), cefepime (CEF: 30 μg), cephpodoxime (CPD: 10 μg), cefotaxime (CTX: 30 μg), ceftazidime (CAZ: 30 μg), rifampicin (RF: 5 μg) (MAST, Merseyside, UK). A. baumannii ATCC 19606 were used as control.
Determination of OXA type by PCR
PCR was carried out for amplifi cation of bla OXA-23-like , bla OXA-24-like , bla OXA-51-like and bla OXA-58-like gene in MDR isolates. Primers for resistance genes were designed as previously described for PCR amplifi cation. [20] Pulsed-fi eld gel electrophoresis These strains were collected from two hospitals from where the most collected isolates came from. A total of 42 MDR A. baumannii were analysed by PFGE using the methods as described by Durmaz et al. [21] We used A. baumannii ATCC 19606 for external reference. Genotyping of all organisms were performed with ApaI (New England Biolabs) digestion. The Lambda Ladder PFG Marker (NEB, US) was used as a molecular size marker. Electrophoresis in a pulsed-fi eld electrophoresis system (Chef Mapper; Bio-Rad Laboratories, Hercules, CA, USA) was by programming two states with the following conditions: temperature 14°C; voltage 6 V/cm; switch angle, 120°; switch ramp 2.2-35 s for 19 h. The gels were stained with ethidium bromide and patterns were photographed with UV gel Doc (BIO-RAD, USA) [ Figure 1 ]. The DNA banding patterns were analyzed using Bionumeric 7.0 software (Apllied maths NV, St-Martens-Latem Beligum). The PFGE DNA patterns obtained were interpreted and compared as described by Tenover et al. [22] 
Results
Anti-microbial susceptibility test and PCR
A total of 42 A. baumannii isolates with MDR phenotype were highly resistant to ciprofl oxacin, piperacillin, ceftazidime [ Table 1 ]. These isolates were susceptible to colistin, polymyxin and tigecylcine. MDR isolates were mainly from sputum (85.7%) and blood (14.3%), from male patients (69%) aged 32 ± 23 years and female (31%) aged 28 ± 27 years, and from patients hospitalized in ICUs (95.2%) and emergency services (4.8%). Following PCR, MDR isolates were identifi ed 92.9% the bla OXA-23-like and 26.2% bla OXA-24-like gene and also totally isolates were identifi ed as carrying the bla OXA-51-like gene and none carried the bla OXA-58-like gene. Some isolates carrying both bla OXA-24-like -bla OXA-23-like 26.2% [ Figure 2 ].
pulsed-fi eld gel electrophoresis
Based on Tenover's criteria, [22] the PFGE patterns of 42 isolates were clustering into six clones (pulsotype): A (10), B (9), C (5), D (4), E (11) and F (3) [ Figure 3 ]. All isolates belonging to the same genotype had similar phenotypes, such as resistance pattern, distribution gene (bla OXA genes) and source of isolation. They showed co-resistance to anti-microbial agents including amikacin, piperacillin, ceftazidime, cefepime, cefotaxime, meropenem, polymyxin B and colistin [ Table 1 ]. Clone E was dominant and widespread in different wards and hospitals. Clone E was dominant in different parts of our hospital and similarity in Table 2 ]. Most pan drug resistant (PDR) isolates to clones A and E [ Table 3 ].
Discussion
Anti-microbial resistance is common among A. baumannii isolates. It is also noteworthy to highlight the fact that Acinetobacter strains are naturally resistant to cephalosporins owing to production of a cephalosporinase (AmpC) that is known to hydrolyze amino-penicillins and fi rst-, second-and third-generation Cephalosporins. [23] MDR A. baumannii strains have been widely reported all over the world, such as Spain, Palestine, Europe, North America, Russia, Brazil, Tahiti, China and also recently reported in Iran. [5, [24] [25] [26] MDR strains often spread, causing outbreaks throughout entire cities, countries and continents. [24] This study is the fi rst such report of MDR A. baumannii isolated in Kermanshah Hospitals in west of the I.R. The study showed low susceptibility rates to most of the clinically available anti-microbial agents for the treatment of infections caused by A. baumannii except for polymyxin B, colistin and tigecylcine that was maintained well, these antibiotics can be helpful in treating infections by A. baumannii. A similar increase in the resistance of A. baumannii isolates to most of the clinically available anti-microbial agents from 2006 to 2010 was reported in Iran. [5, 25] Different mechanisms are involved in the resistance to imipenem (or meropenem) in A. baumannii. β-lactamase is one important factor. bla OXA-23-like was the most prevalent carbapenemase among imipenem-resistant isolates in Iran. [4] Carbapenem resistance is becoming more and more common among A. baumannii isolates in I.R. hospitals in recent years. [4, 5, 15, 25] In this study, 93% of MDR A. baumannii carrying bla OXA-23-like and 26.2% of isolates carrying bla OXA-24-like . All isolates were carriers for genes encoding the enzyme bla OXA-51-like , an enzyme that naturally exists in A. baumannii and confi rming their identity as A. baumannii. The bla OXA-58-like is not found among the isolates. The bla OXA-23-like was associated with Carbapenemase (P = 0.003) because the bla OXA-23-like gene associated with Tn2006 is capable of transposing from 9  0  5  4  7  2  Clone C  5  1  5  0  5  0  2  3  5  0  Clone D  3  2  4  0  3  1  4  0  2  2  Clone E  10  3  11  0  10  1  9  2  10  1  Clone F  3  2  3  0  3  0  3 bacteria to bacteria and could be located on the plasmid [27] and also class 1 integrons plays an important role in spread of antibiotic resistance in MDR A. baumannii [28] For better understanding the epidemiology and spread of bacteria, particular in outbreaks of nosocomial infection, a number of molecular typing systems have been developed. [3] PFGE analysis has been used with excellent data in epidemiologic studies of numerous bacterial outbreaks and is gold standard for molecular epidemiologic. [29] The results of this study support the contention that clonal spread was the main reason for the increasing trend of MDR resistance in our hospital. It is increasingly recognized that A. baumannii is clonal relatedness in different wards of hospitals and that a large part of MDR A. baumannii in west of Iran. This study was conducted to understand the molecular epidemiology of MDR A. baumannii in hospitals, with the aim of identifying predominant clonal lineages currently circulating in this area. Isolates in this study with PFGE profi les E, A and B were believed to be endemic in the ICU and emergency area throughout the years.
Conclusion
An isolate from the emergency of these hospitals had an indistinguishable isolates PFGE profi le and similar resistance profi le to isolates from ICU, suggesting likely transmission from ICU to emergency via patient or hospital staff contact, however, the direction was unknown. Early recognition of the presence of MDR A. baumannii clones is useful for preventing their spread within the hospital environment, [30] for this point sampling via patient or hospital staff in my study should be controlled by several time in during year of study. In conclusion, A. baumannii isolates from the ICU and emergency at Kermanshah from March 2010 to December 2011 had high resistance rates to the majority of anti-microbials commonly used in hospitals. Only tigecylcine and colistin remains effective for the treatment of infections caused by MDR A. baumannii. PFGE analysis confi rmed a persistent clone of MDR A. baumannii in the ICU and emergency environment. Overall, our study indicated that MDR A. baumannii strains are spreading in west of Iran. 
